Impact of PM2.5 exposure on mortality and tumor recurrence in resectable non-small cell lung carcinoma
Open Access
- 21 October 2024
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-9
Abstract
This study aimed to explore the impact of PM 2.5 exposure on survival, post-operative outcomes, and tumor recurrence in resectable non-small cell lung cancer (NSCLC) patients. The study cohort comprised 587 patients at Chiang Mai University Hospital between January 1, 2010, and December 31, 2017. Patients were categorized based on their residents’ average PM 2.5 concentration into two groups: exposed (PM 2.5 ≥ 25 µg/m3 annual mean) and unexposed (PM 2.5 < 25 µg/m3 annual mean). The exposed group had 278 patients, while the unexposed group had 309 patients. Baseline differences in gender and surgical approach were observed between the groups. Multivariable regression analysis revealed that patients in the exposed group had a higher risk of death (HR 1.44, 95% CI, 1.08–1.89, p = 0.012). However, no significant associations were found between PM 2.5 and post-operative pulmonary complications (RR 1.12, 95% CI, 0.60–2.11, p = 0.718), in-hospital mortality (RR 1.98, 95% CI, 0.40–9.77, p = 0.401), and tumor recurrence (HR 1.12, 95% CI, 0.82–1.51, p = 0.483). In conclusion, a PM 2.5 concentration ≥ 25 µg/m3 annual mean was associated with decreased overall survival and a potential increase in in-hospital mortality among resectable NSCLC patients. Larger studies with extended follow-up periods are required to validate these findings.Keywords
All Related Versions
This publication has 20 references indexed in Scilit:
- The PM2.5 concentration reduction improves survival rate of lung cancer in BeijingScience of The Total Environment, 2022
- Short-term association of PM2.5/PM10 on lung cancer mortality in Wuhai city, China (2015–2019): a time series analysisEuropean Journal Of Cancer Prevention, 2022
- Regional interaction of lung cancer incidence influenced by PM2.5 in ChinaScience of The Total Environment, 2022
- Risk factors and cancer recurrence associated with postoperative complications after thoracoscopic lobectomy for clinical stage I non‐small cell lung cancerThoracic Cancer, 2019
- Fine Particulate Matter (PM2.5) Promoted the Invasion of Lung Cancer Cells via an ARNT2/PP2A/STAT3/MMP2 PathwayJournal of Biomedical Nanotechnology, 2018
- Long-Term PM2.5 Exposure and Respiratory, Cancer, and Cardiovascular Mortality in Older US AdultsAmerican Journal of Epidemiology, 2017
- Recurrence Risk Factors Analysis for Stage I Non-small Cell Lung CancerMedicine, 2015
- The carcinogenicity of outdoor air pollutionThe Lancet Oncology, 2013
- The Role of Reactive Oxygen Species and Oxidative Stress in Mediating Particulate Matter InjuryClinics in Occupational and Environmental Medicine, 2006
- Inflammatory Lung Injury after Bronchial Instillation of Air Pollution ParticlesAmerican Journal of Respiratory and Critical Care Medicine, 2001